SYNLOGIC, INC.
Profile
Company Names
SYNLOGIC, INC.
MIRNA THERAPEUTICS, INC.
Addresses
301 BINNEY STREET, SUITE 402, CAMBRIDGE, MA 02142
2150 WOODWARD ST., SUITE 100, AUSTIN, TX 78744
Phone Numbers
617-401-9975
512-681-5200
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2007
State Incorporated:
DELAWARE
Total Amount Raised:
$140,539,514.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-06-11
$79,999,992.00
$79,999,992.00
$0.00
Equity
3
2015-03-31
$41,789,527.00
$45,000,000.00
$3,210,473.00
Equity
2
2012-10-22
$17,249,995.00
$34,499,990.00
$17,249,995.00
Equity
1
2011-08-10
$1,500,000.00
$1,500,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER
BARRETT
DIRECTOR
VITAE PHARMACEUTICALS, INC
| HELICOS BIOSCIENCES CORP
| SIRION HOLDINGS, INC.
| ZAFGEN, INC.
| MOLECULAR BIOMETRICS INC
| STROMEDIX INC
| INFACARE PHARMACEUTICAL CORP
| JENAVALVE TECHNOLOGY INC
| MNEMOSYNE PHARMACEUTICALS INC
| SYNLOGIC, INC.
| PLAYGROUND VENTURES, L.P.
| PLAYGROUND GLOBAL, LLC
| SUBPAC, INC.
| SYNLOGIC, LLC
| INDALO THERAPEUTICS, INC.
| BINGHAM NATURAL WINES, LLC
| OBSIDIAN THERAPEUTICS, INC.
| SYNLOGIC, INC.
| LARIMAR THERAPEUTICS, INC.
| PLAYGROUND COMPUTE, L.P.
| ARTIFICIAL, INC.
| ANJUNA SECURITY, INC.
| MOSAIC ML, INC.
| PERKINELMER INC
| PLAYGROUND ACQUIRE, L.P.
| PLAYGROUND OMEGA, L.P.
| PLAYGROUND HELIX, L.P.
| PSIQUANTUM, CORP.
| PLAYGROUND OMEGA 2, L.P.
| XLIGHT INC.
| PLAYGROUND GENESIS, L.P.
| PLAYGROUND VENTURES IV, L.P.
| PLAYGROUND VENTURES AFFILIATES IV, L.P.
AOIFE
BRENNAN
EXECUTIVE OFFICER, DIRECTOR
COREY
GOODMAN
DIRECTOR
LIMERICK BIOPHARMA INC
| IPIERIAN, INC.
| VENBIO GLOBAL STRATEGIC FUND, L.P.
| SECOND GENOME, INC.
| MIRNA THERAPEUTICS, INC.
| SOLSTICE BIOLOGICS LLC
| LABRYS BIOLOGICS, INC.
| VENBIO SELECT FUND LTD.
| VENBIO SELECT FUND LLC
| ALEXO THERAPEUTICS LTD
| CHECKMATE PHARMACEUTICALS, INC.
| VENBIO GLOBAL STRATEGIC FUND II L.P.
| NFLECTION THERAPEUTICS, INC.
| VENBIO GLOBAL STRATEGIC FUND III, L.P.
| TALLAC THERAPEUTICS, INC.
| VENBIO GLOBAL STRATEGIC FUND IV, L.P.
| ATTRALUS, INC.
| INSAMO INC.
| VENBIO GLOBAL STRATEGIC FUND V, L.P.
ELAINE
JONES
DIRECTOR
CHAU
KHUONG
DIRECTOR
CERAPEDICS INC
| AERPIO THERAPEUTICS, INC.
| INSPIRE MEDICAL SYSTEMS, INC.
| PIERIS PHARMACEUTICALS, INC.
| SYNLOGIC, LLC
| AERPIO PHARMACEUTICALS, INC.
| SYNLOGIC, INC.
| SYNLOGIC, INC.
| PERFUSE THERAPEUTICS, INC.
| GRAYBUG VISION, INC.
| NOCTRIX HEALTH, INC.
| GENNAO BIO, INC.
| RESTORA MEDICAL, INC.
NICK
LESCHLY
DIRECTOR
ED
MATHERS
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| INTARCIA THERAPEUTICS, INC
| ENVISIA THERAPEUTICS INC.
| SYNLOGIC, INC.
| MIRNA THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SYNLOGIC, LLC
| TREVI THERAPEUTICS, INC.
| AKOUOS, INC.
| RENEO PHARMACEUTICALS, INC.
| SENTI BIOSCIENCES, INC.
| MIRUM PHARMACEUTICALS, INC.
| CURZION PHARMACEUTICALS, INC.
EDWARD
MATHERS
DIRECTOR
RA PHARMACEUTICALS, INC.
| RHYTHM PHARMACEUTICALS, INC.
| SATORI PHARMACEUTICALS INC
| MIRNA THERAPEUTICS, INC.
| RHYTHM HOLDING COMPANY, LLC
| LUMENA PHARMACEUTICALS, INC.
| LUMOS PHARMA, INC.
| AMPLYX PHARMACEUTICALS, INC.
| LIQUIDIA TECHNOLOGIES INC
| INOZYME PHARMA, INC.
| SYNLOGIC, INC.
| AFFINIA THERAPEUTICS INC.
| CODE BIOTHERAPEUTICS, INC.
| TREVI THERAPEUTICS, INC.
| SORRISO PHARMACEUTICALS, INC.
| MBX BIOSCIENCES, INC.
| CARDURION PHARMACEUTICALS, INC.
| BRENIG THERAPEUTICS, INC.
| SENTI BIOSCIENCES, INC.
| SENTI BIOSCIENCES HOLDINGS, INC.
| SENTI HOLDINGS, INC.
| SENTI BIOSCIENCES, INC.
MICHAEL
POWELL
DIRECTOR
ALVINE PHARMACEUTICALS INC
| TRIUS THERAPEUTICS INC
| ASCENTA THERAPEUTICS, INC.
| ARCHIPELAGO LEARNING, INC.
| OBJECTVIDEO INC
| EXCELLENT ENERGY SOLUTIONS, LLC
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| MIRNA THERAPEUTICS, INC.
| SUPPLY VISION, INC.
| PASSPORT SYSTEMS INC
| CATALYST BIOSCIENCES INC
| CHIGWELL LTD
| MERCURY MEDIA SCIENCE B LTD
| CHECKMATE PHARMACEUTICALS, INC.
| DAUNTLESS 1, INC.
| DAUNTLESS 2, INC.
| E-CIRCUIT MOTORS, INC.
| PIONYR IMMUNOTHERAPEUTICS, INC.
| TM TECHNOLOGIES INC
| GALERA THERAPEUTICS, INC.
| SYNLOGIC, INC.
| AEOVIAN PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-06-11
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-03-31
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

